Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

Call for Abstracts - SNO Pediatric Neuro-Oncology Basic and Translational Research Conference

Submission Deadline - Friday, January 20, 2017

Read Full Story

CNS Anticancer Drug Discovery and Development Conference

Register Now!

Read Full Story

Neuro-Oncology Review Course at SNO

November 16, 2016. Register in conjunction with the SNO Annual Meeting

Read Full Story
View All News


2nd CNS Anticancer Drug Discovery/Development Conference

Read Full Story


2016 Career Development and Networking Reception

Read Full Story


CNIO Frontiers Meeting - Primary and Secondary Brain Tumors

Read Full Story

Neuro-Oncology Impact Factor Rises

The Society for Neuro-Oncology is pleased to announce that the impact factor for Neuro-Oncology has risen to 6.180, putting the journal among the top ten titles in Clinical Neurology by the Science Citation Index.

This new, higher ranking reinforces Neuro-Oncology’s position as the leading journal in the field.

With a wealth of peer-reviewed articles and reviews, topical symposia, abstracts of annual meetings, and society news from around the world, the journal continues its mission to provide superior and rapid publication of information in all areas of neuro-oncology.

The three recent most highly cited papers are free to read via the below links.


Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

Authors: de Groot, John F.; Fuller, Gregory; Kumar, Ashok J.; et al.


A multigene predictor of outcome in glioblastoma

Authors: Colman, Howard; Zhang, Li; Sulman, Erik P.; et al.


A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

Authors: Raizer, Jeffrey J.; Abrey, Lauren E.; Lassman, Andrew B.; et al.


For more information